Ondansetron Tablet, Orally Disintegrating
Product Images NDC 55154-4567

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-4567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

26aff90c 49ea 46ac Bbf3 C188c2b061c9

Ondansetron 4 mg orally disintegrating tablets label displaying product name, strength, form, and quantity (10 tablets). It includes storage instructions, administration warnings, and manufacturer details, noting distribution by Cardinal Health 107, LLC. The label also contains an NDC barcode and cautions for phenylketonurics.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of ondansetron hydrochloride dihydrate, the active ingredient in ondansetron 4 mg orally disintegrating tablets by Cardinal Health 107, LLC.*

FDA Label Image

Spl-ondansetron-chemical-structure (Spl Ondansetron Chemical Structure)

Chemical structure of ondansetron, the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.